NCT02608203View on ClinicalTrials.gov

[68 Ga]-DOTANOC PET/CT in GEP-NETs

PHASE2/PHASE3CompletedINTERVENTIONAL
Enrollment

18

Participants

Timeline

Start Date

May 26, 2016

Primary Completion Date

June 24, 2019

Study Completion Date

June 30, 2020

Conditions
Gastroenteropancreatic Neuroendocrine Tumors
Interventions
DRUG

[68Ga]-DOTANOC PET/CT

Trial Locations (1)

Unknown

AP-HM, Marseille

All Listed Sponsors
lead

Assistance Publique Hopitaux De Marseille

OTHER

NCT02608203 - [68 Ga]-DOTANOC PET/CT in GEP-NETs | Biotech Hunter | Biotech Hunter